0
Ironwood Pharmaceuticals, Inc. Banner Image

Ironwood Pharmaceuticals, Inc.

  • Ticker IRWD
    Exchange NASDAQ More
  • Industry Drugs - Generic More
  • Sector Healthcare More
Ironwood Pharmaceuticals, Inc. Logo Image
  • 201-500 Employees
  • Based in Cambridge, Massachusetts
Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name inMore the United States and Constella name in the European Union.
Ironwood Pharmaceuticals, Inc.

Most Recent Annual Report

Ironwood Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Ironwood Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports